What is Cagrilintide?
The short answer
Cagrilintide is a new, long-lasting, lab-made form of a hormone the body makes.
What it is
Amylin mimic that slows eating and stomach emptying.
What people look into
Weight
- 5 sources
- Status as of
- How we source
- Ellum doesn't sell peptides.
Get updates on Cagrilintide
What it is
- Type
- Long-acting amylin analog (peptide)
- Also known as
- cagri, cagrilintide peptide
- How it works
- Amylin mimic that slows eating and stomach emptying.
Regulatory status
Investigational (phase 3) How we label status
As of October 4, 2026, Cagrilintide is not FDA-approved for any use and is not on FDA's 503A bulks list. It is in phase 3 trials.
- Federal (FDA)
- Investigational, not filed as monotherapy
- 503A compounding
- Not eligible (FDA: 'cannot be used in compounding under federal law') (as of October 1, 2026)
US enforcement actions
5 US enforcement actions since 2024.
Actions by US federal and state agencies whose documents name Cagrilintide. Each row links to the government's own document.
Scroll sideways to see all columns.
US enforcement actions table
| Date | Agency | Action | Document |
|---|---|---|---|
| US Justice Department | Indictment | Justice Department document, indictment, April 1, 2026, on justice.gov | |
| FDA | Warning letter | FDA document, warning letter, March 31, 2026, on fda.gov | |
| FDA | Warning letter | FDA document, warning letter, December 8, 2025, on fda.gov | |
| FDA | Warning letter | FDA document, warning letter, December 10, 2024, 1 of 2 that day, on fda.gov | |
| FDA | Warning letter | FDA document, warning letter, December 10, 2024, 2 of 2 that day, on fda.gov |
References
Sources as of October 4, 2026